10x Genomics price target raised to $37 from $22 at Morgan Stanley

Morgan Stanley analyst Kallum Titchmarsh raised the firm's price target on 10x Genomics to $37 from $22 and keeps an Equal Weight rating on the shares. The firm is updating its model ahead of the earnings report.